Albumedix seeks partners and collaborators to unlock the full potential of native and engineered albumin to create superior biotherapeutics
Albumedix has already established a range of partnerships and we are constantly seeking new relationships with innovators who share our vision; to create superior albumin-based biotherapeutics for improved patient care.
At Albumedix we work through a simple and agile partnership model that quickly allows customers to evaluate the benefits of our albumin-based products and technologies. The model is based on four overall phases to ensure an effective decision-making process and complete transparency at every stage:
Inquiry – after an initial interest has been established, we quickly ensure that the overall areas of interest are aligned and that the right people are involved.
Scoping – once the overall objectives are determined, a dedicated group of technical and commercial experts work together with you to outline a more detailed project plan to determine how best to assess the feasibility of our solutions in your application.
Feasibility - to evaluate the technical feasibility. Either a joint or individual proof-of-concept study is performed. This can range from simple analytical testing to larger in vivo studies with responsibilities clearly defined and deadlines predetermined.
Agreement – following feasibility testing we jointly review the outcome and determine the best way forward, for instance through a supply and/or license agreement.
Albumedix is also interested in pioneering technologies that enhance our offering and internal R&D efforts. Consequently, we are frequently evaluating complementary technologies and have secured strong solution collaborations that are already benefitting our partners.
To learn more about our solutions and way of working with us please contact us.